The excuse that comes back every year
There are two times of year when pipelines fill up with “stalled” deals: July–August and the last quarter. The explanation that circulates among sales teams is always the same: it’s the season — buyers are busy, budgets are locked, we’ll pick this up in September.
The calendar makes for a perfect alibi because it contains a partial truth — there are periods when decisions get delayed and sales cycles stretch out. The problem is what that explanation keeps hidden: in most cases where a deal “pauses for the summer,” if you go back and review the conversations that preceded it, the pain was never confirmed as urgent. The deal didn’t die in August. What August exposed was something that had been broken from day one.
The quick diagnosis: slow season or discovery problem?
There’s a direct way to know which situation you’re really dealing with. For every deal that has been sitting still for more than three weeks, answer two questions about what actually happened in prior conversations:
- Can the rep explain, in the buyer’s own words, what happens to the business if this problem goes unresolved?
- Is there a specific date — tied to a real business need, not the rep’s sales cycle — by which the buyer needs this resolved?
If the rep hesitates on either one, the problem isn’t the calendar. It’s the discovery. A slow season can delay a decision that’s already in motion; it cannot create urgency that never existed.
Declared pain vs. confirmed pain
There’s a critical difference between a buyer who says “yes, we have that problem” and one who can articulate what it costs them. The first is declared pain: it means the problem exists. The second is confirmed pain: it means the problem matters enough to act on.
Discovery that stops at declared pain produces a pipeline full of deals that “are going well” and never close. Every deal has a plausible story, the buyer was friendly, the fit seems clear — but when August or December arrives, suddenly nothing is urgent. The season didn’t create that void: it just made it visible.
Discovery that reaches confirmed pain does one thing differently: it doesn’t accept “yes, we have it” as a final answer. It keeps digging until the buyer articulates the consequence of not solving the problem — and how soon that consequence becomes unacceptable.
The three signals of weak discovery
In deals that stall during the slow season, three signals show up with remarkable consistency. None of them get resolved by sending more emails:
The rep knows the problem exists, but doesn’t know what happens to the business if it stays unresolved. “It’s important to them” is not a consequence. “It’s costing them X per month and that number is growing” is.
The deal has a date on the rep’s pipeline, not on the buyer’s calendar. “They’re thinking about Q4” is not a timeline. “They need it live before the annual close because X process depends on it” is.
Someone expressed interest, but it’s not clear who signs off. Your contact may be a genuine champion — but if they don’t have buying authority, the deal won’t move without the active backing of whoever does.
These three signals are independent of the time of year. If a deal has them in July, it will still have them in September. The season changes; the discovery gap doesn’t.
Discovery that builds urgency (instead of waiting for it)
The most common mistake with stalled deals is waiting for urgency to appear on its own. Urgency doesn’t appear: it’s built in discovery, or it doesn’t exist.
Discovery that builds urgency isn’t a longer question checklist. It’s a discipline of going beyond the declared problem to the real cost of leaving it unresolved. The shift is subtle but it determines everything that follows: the conversation stops revolving around product features and starts revolving around the cost of the buyer’s inaction.
“What does each month without resolving this cost you?” — not as rhetoric, but as a question that requires a number or a concrete business impact.
“What happens to the business if you reach year-end with this exactly as it is today?” — it connects inaction to a real consequence within a specific horizon.
A buyer who can answer those two questions precisely doesn’t need the rep to manufacture urgency: they already have it. Discovery’s job is to help them see it clearly, not to invent it.
The soft close and how to escape it
Weak discovery always has a twin that shows up with it: the soft close. When the rep doesn’t have confirmed pain, they avoid asking for a decision because they’re afraid the buyer will say no. The result is a deal that neither dies nor closes — the worst possible outcome, because it consumes team time indefinitely without producing anything.
The rep’s logic is understandable: if I push and they say no, I lose the deal. But that deal is already lost — nobody knows it yet. The soft close doesn’t protect the deal; it only delays the moment the team accepts that reality.
The way out isn’t sending more “just checking in” follow-ups. It’s earning the right to ask for a decision by going back to discovery with concrete questions: “When we spoke in August, you mentioned X was a top priority. How has that evolved?” or “Is it still a priority this quarter, or has it shifted due to other things?”
Those questions do one thing: they force the buyer to take a position. If the problem is still urgent, the conversation moves forward. If it’s not, the deal comes out of the pipeline — and that’s also a valuable outcome.
Why more follow-ups won’t fix this
The most common reaction when a deal goes quiet is to increase the frequency of contact. But if the discovery was weak, more touchpoints only add noise without changing the signal. What needs to change is the quality of the conversation, not its frequency.
A follow-up that repeats “just wanted to see how things are going” on a deal without confirmed pain isn’t advancing anything: it’s delaying the moment of reckoning with the fact that that deal was never real. The calendar isn’t the problem. The problem is that nobody yet knows for certain whether there’s an urgent problem on the buyer’s side.
Auditing this deal by deal — does it have an articulated consequence? does it have a business timeline? is the economic buyer identified? — is exactly what Performy runs automatically across the 100% of calls. Not just the deals someone decided to review this week. Every conversation is evaluated against the same questions, and the system flags — without anyone having to remember to ask — when the consequence is missing, when the timeline belongs to the rep and not the buyer, when the only contact on record has no buying authority.
